Market Herald logo

Subscribe

Be the first with the news that moves the market
  • IMV Inc (TSX:IMV) has announced that the company will present at the 2020 BIO CEO and Investor Conference next month.
  • Management team members will give the presentation on February 10th, at the Marriott Marquis Hotel in New York.
  • A live webcast and replay of the presentation will be accessible online.
  • IMV’s share price is up 0.33 per cent, with shares trading at $6.16 apiece.

Representatives from biopharmaceutical company IMV Inc (IMV) will give a presentation at the BIO CEO and Investor Conference in February. The two-day conference will take place at the Marriott Marquis Hotel in New York City.

The occasion will bring together investors, industry analysts, and senior executives from biotechnology companies. The event is a great opportunity to let investors know about the novel class of immunotherapies which IMV is currently pioneering.

The conference will take place on February 10th and 11th, with company presentations on both days. IMV’s presentation is scheduled for Monday February 10th, at 9:30am Eastern Standard Time.

A live webcast of the presentation will be made available on the investors section of IMV’s website, under Events, Webcasts, and Presentations.

A replay will also be accessible, roughly one hour after the presentation. It will continue to be available for approximately 30 days.

IMV’s share price is up 0.33 per cent, with shares trading at $6.16 apiece.

More From The Market Herald

" WELL Health NCIB suggests undervaluation

WELL Health has entered into an automatic share purchase plan to facilitate share repurchases.

" Best biotech stocks to buy in 2023

Innovation continues to drive the broader healthcare market, and the best biotech stocks are at the forefront of new developments and therapies to
Lifeist

" Lifeist to acquire the fast-growing ‘Zest’ brand

Lifeist Wellness (TSXV:LFST) has signed a share purchase agreement to acquire the Zest brand.

" Advancing environmental work at the Frances Creek barium project

Voyageur Pharmaceuticals (TSXV:VM) has finished environmental and geotechnical field work at its Frances Creek project site.